Portfolio Companies News
January 13, 2021GenSight Biologics Announces Public...
Bilateral improvement in visual acuity from a unilateral injection of gene therapy – consistent with REVERSE trial findings Significant improvement against visual acuity nadir Paris, France, January 13, 2021, 7:30 am CET – GenSight Biologics (Euronext: SIGHT, I... read more
January 7, 2021CARISMA Therapeutics Completes Seri...
PHILADELPHIA, Jan. 7, 2021 /PRNewswire/ -- CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced today that it has completed its Series B equity financing providing for gross proceeds of $47 million, bringing CARISMA'... read more
January 6, 2021Spruce Biosciences Provides Corpora...
-CAHmelia Adult Classic CAH Program Underway in U.S. and Europe- -Initiation of Phase 2 Pediatric Classic CAH Program Anticipated in Second Half of 2021- -Initiation of Phase 2 Polycystic Ovary Syndrome Program Anticipated in Second Half of 2021- -New Patent Issuance Extends Tildacerfont Patent E... read more
January 6, 2021Strongbridge Biopharma plc Announce...
Expects to Report KEVEYIS® (dichlorphenamide) Fourth Quarter 2020 Revenue of Approximately $8.2 Million and Full-Year 2020 Revenue of Approximately $30.7 Million, a 41.5 Percent Increase over 2019 Revenue of $ $21.7 Million ~ ~ Targets Full-Year 2021 KEVEYIS® (dichlorphenamide) Revenue G... read more
January 6, 2021Targovax grants IOVaxis 3 months ex...
COVID-19 have caused delays to submission and processing of the regulatory application to initiate clinical development in China Due to the unforeseen delays, Targovax has extended the term of IOvaxis´s license option by 3 months, otherwise the agreement remains unchanged Oslo, Norway 6 ... read more
November 03, 2020Q3 2020 General Market Overview
Since the start in 1996, HealthCap funds have invested in 118 portfolio companies.
46 of the portfolio companies have been taken public on nine different markets.
26 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 12 companies with a valuation of USD 1 billion or more.